Skip to main content
. 2021 Sep 24;12:759267. doi: 10.3389/fphar.2021.759267

FIGURE 2.

FIGURE 2

Inhibition of LINC01001 depresses crizotinib-resistance of NSCLC cells. (A) RT-qPCR detected the levels of LINC01001. (B) CCK-8 assay evaluated the viability of crizotinib-resistant NSCLC cells. (C) EdU assay assessed the proliferation of crizotinib-resistant NSCLC cells. (D) Western blot measured the levels of proliferation-related proteins, including PCNA and Ki-67. (E) FACs assessed apoptosis of crizotinib-resistance NSCLC cells. (F) TUNEL staining performed to evaluate apoptosis of crizotinib-resistant NSCLC. **p < 0.01, ***p < 0.001 vs sh-NC group. Error bars represent SD. Data represent three independent experiments.